|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/40 | (2006.01) |
| A61K 31/4704 | (2013.01) | ||
| A61K 31/4704 | (2006.01) | ||
| A61K 31/40 | (2013.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61K 9/4858 | (2013.01) |
| (11) | Patento numeris | 3603634 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19180535.7 |
| Europos patento paraiškos padavimo data | 2005-05-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-02-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2025-02-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 0411056 | 2004-05-18 | GB |
| (72) |
Collingwood, Stephen Paul , GB
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
Novartis Pharma GmbH , Brunner Strasse 59, 1230 Wien, AT |
| (54) | PHARMACEUTICAL COMPOSITION CONTAINING GLYCOPYRROLATE AND A BETA2 ADRENOCEPTOR AGONIST |
| PHARMACEUTICAL COMPOSITION CONTAINING GLYCOPYRROLATE AND A BETA2 ADRENOCEPTOR AGONIST |